Calyxt (CLXT) Misses Q2 EPS by 61c

Calyxt (NASDAQ: CLXT) reported Q2 EPS of ($0.80), $0.61 worse than the analyst estimate of ($0.19). Revenue for the quarter came in at $4.62 million versus the consensus estimate of $6.14 million.

As of June 30, 2021, Cellectis, including Calyxt, had $257 million in consolidated cash, cash equivalents, current financial assets and restricted cash of which $238 million are attributable to Cellectis on a stand-alone basis. This compares to $274 million in consolidated cash, cash equivalents, current financial assets and restricted cash as of December 31, 2020, of which $244 million was attributable to Cellectis on a stand-alone basis.

For earnings history and earnings-related data on Calyxt (CLXT) click here.

You May Also Be Interested In

• Tesla plans 'flying' Roadster stunt at SpaceX Texas site as early as August
• HeartCore Enterprises, Inc. (HTCR) Misses Q2 EPS by 185c
• Boost Run, Inc. (BRUN) Reports Q2 Revenue of $31.1M